Early data indicates that ketogenic supplements are a possible, safe, and effective treatment for Alzheimer’s disease and other forms of dementia. Dr. Stephen Cunnane has been working in this field for decades and has seen the research evolve. However, he has also observed a very slow adoption in clinical practice. A professor at the Université de Sherbrooke, Dr. Cunnane shares his journey in this field, explains why he began researching ketones, how ketogenic therapies could revolutionize dementia treatment, and what needs to be done to make them more widely accepted.
